These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32992469)

  • 1. Paediatric Formulation: Design and Development.
    Lopalco A; Denora N
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best practices for selection of excipients for paediatrics - Workshop reflection.
    Salunke S; Clapham D; Agrawal A; Hughes K; Nunn T
    Eur J Pharm Biopharm; 2021 Mar; 160():77-81. PubMed ID: 33400989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
    Freerks L; Sommerfeldt J; Löper PC; Klein S
    Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric Drug Development and Formulation Design-a European Perspective.
    Van Riet-Nales DA; Kozarewicz P; Aylward B; de Vries R; Egberts TC; Rademaker CM; Schobben AF
    AAPS PharmSciTech; 2017 Feb; 18(2):241-249. PubMed ID: 27270905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet technological demands in orodispersible films for age-appropriate paediatric drug delivery.
    Chacko IA; Ramachandran G; Sudheesh MS
    Drug Deliv Transl Res; 2024 Apr; 14(4):841-857. PubMed ID: 37957474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of medicines for children.
    Nunn T; Williams J
    Br J Clin Pharmacol; 2005 Jun; 59(6):674-6. PubMed ID: 15948931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.
    Kogermann K; Lass J; Nellis G; Metsvaht T; Lutsar I
    Curr Pharm Des; 2017; 23(38):5779-5789. PubMed ID: 28950820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conference report: formulating better medicines for children: 4th European Paediatric Formulation Initiative conference.
    Walsh J; Mills S
    Ther Deliv; 2013 Jan; 4(1):21-5. PubMed ID: 23323778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration.
    Lopalco A; Denora N; Laquintana V; Cutrignelli A; Franco M; Robota M; Hauschildt N; Mondelli F; Arduino I; Lopedota A
    Int J Pharm; 2020 Jan; 574():118922. PubMed ID: 31836482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
    Chandrasekaran P; Kandasamy R
    AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Educational paper: formulation-related issues in pediatric clinical pharmacology.
    Tuleu C; Breitkreutz J
    Eur J Pediatr; 2013 Jun; 172(6):717-20. PubMed ID: 23111761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.
    Salunke S; Liu F; Batchelor H; Walsh J; Turner R; Ju TR; Tuleu C;
    AAPS PharmSciTech; 2017 Feb; 18(2):257-262. PubMed ID: 27422653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population.
    Salunke S; O'Brien F; Cheng Thiam Tan D; Harris D; Math MC; Ariën T; Klein S; Timpe C;
    Adv Drug Deliv Rev; 2022 Nov; 190():114507. PubMed ID: 36049580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring paediatric oral suspension development: Challenges, requirements, and formulation advancements.
    Gaikwad SS; Morales JO; Lande NB; Catalán-Figueroa J; Laddha UD; Kshirsagar SJ
    Int J Pharm; 2024 May; 657():124169. PubMed ID: 38688428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric formulation issues identified in Paediatric Investigation Plans.
    Quijano Ruiz B; Desfontaine E; Arenas-López S; Wang S
    Expert Rev Clin Pharmacol; 2014 Jan; 7(1):25-30. PubMed ID: 24308789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation.
    Laquintana V; Asim MH; Lopedota A; Cutrignelli A; Lopalco A; Franco M; Bernkop-Schnürch A; Denora N
    Int J Pharm; 2019 Dec; 572():118820. PubMed ID: 31706864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical and operational considerations related to paediatric oral drug formulation: An industry survey.
    Van der Veken M; Brouwers J; Budts V; Lauwerys L; Pathak SM; Batchelor H; Augustijns P
    Int J Pharm; 2022 Apr; 618():121670. PubMed ID: 35304242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.